RESULTS
24 matchesCustom Gene-Editing Therapies for Rare Diseases Could Win Faster Approvals Under FDA Draft Plan, Not Yet Final
The FDA's draft guidance could streamline approval of gene-editing therapies tailored to individual mutations, while families and experts weigh safety, affordability, evidence requirements, and access challenges.
Namibia says ramping up Ebola preparedness at entry points
Windhoek: Namibia,following the spread of the Ebola disease across several countries, hasintensified disease surveillance and reinforced preparedness...
Is Gluten-Free Bread Better For You Than Regular Bread?
Even if you don't suffer from celiac disease or some other gluten sensitivity, you may wonder if gluten-free bread is better for you. One dietitian explains.
Days of Our Lives Star Robert Kelker-Kelly’s Cause of Death Revealed After Sudden Symptoms
Day of Our Lives alum Robert Kelker-Kelly, who died Oct. 3 hours after experiencing pain in his chest and arm, was determined to have died of heart disease,…
An Overlooked Immune Cell Killed The Deadliest Form of Lung Cancer in Lab Tests
Fewer than 7% survive this disease. ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.
Brett Myers, sheriff for 24 years, dies at 56
Pullman law enforcer succumbs to a rare neurological disease
Climate shocks increase health risks for Africa's most vulnerable
Climate change is already reshaping Africa's health landscape, as rising temperatures, erratic rainfall, droughts, and floods worsen food insecurity, heighten infectious disease risks, and strain already fragile health…
Community spirometry hubs test 4,000 patients across Cardiff and Vale
More than 4,000 patients across Cardiff and the Vale of Glamorgan have already benefited from new community spirometry hubs designed to improve lung disease diagnosis.
J&J’s Tremfya Sustains Crohn’s Remission Through 48 Weeks
SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) reported that its Crohn’s disease treatment Tremfya sustained or improved fistula remission through 48 weeks in a Phase 3…
Lifileucel Shows 50% Response Rate in Refractory UPS and Liposarcoma
Data presented at ESMO Congress 2026 show lifileucel met its feasibility end point in refractory sarcoma, with 80% disease control among 10 patients.
Multivalent pDNA vaccine prolongs BCG-mediated control of M. tuberculosis
Mycobacterium tuberculosis remains a leading cause of infectious disease-mediated death, with 10.8 million reported cases of active disease and 1.25 million deaths only in 2023. The Bacillus Calmette-Guerin…
Annovis Targets 2027 Alzheimer’s Drug Data Readout
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) will present updates on its experimental Alzheimer’s disease treatment buntanetap at a November medical conference in Boston as the Malvern-based…
Patient CRM Modernization: Four Decisions Technology Can’t Make for You
Consider a daughter who signs up for disease information on behalf of her father. Weeks later, he enrolls in copay assistance and asks another website for updates. To…
New cacao variety could help protect global chocolate supply from disease
Chocolate lovers may not realize it, but the future of one of the world's most popular foods is increasingly under pressure. Diseases, shifting weather patterns and other environmental…
Medicenna’s MDNA-209 extends survival in GVHD models
Medicenna Therapeutics Corp. has released new preclinical data for MDNA-209, a long-acting IL-2/IL-15 superantagonist that effectively blocks the overactive CD122/CD132 pathway responsible for autoimmune diseases. The results demonstrated…
ADX-038 shows sustained alternative complement inhibition
Researchers from Adarx Pharmaceuticals Inc. presented preclinical and early clinical data on agazisiran (ADX-038), a double-stranded, GalNAc-conjugated siRNA developed to reduce complement factor B (CFB) expression.
MARY-1 improves kidney function in DKD and AKI models
The serotonin 5-HT2B receptor has been implicated in maladaptive responses to renal injury, including inflammatory and fibrotic signaling, making it a potential therapeutic target. Researchers from the University…
Spyre Therapeutics antibodies, alone and in combination, ameliorate IBD phenotype
Spyre Therapeutics Inc. has developed and presented data for a series of antibodies with extended half-life, and their combination, for the treatment of inflammatory bowel disease (IBD). These…
Why we’ll never have another Black Death
The death of a worker at a Russian plague lab was alarming, but the disease is extremely unlikely to become a worldwide problem as it has in the…
Nurse treating Ebola patient killed by machete-wielding mob after being accused of spreading deadly disease
A HERO nurse working to contain the spread of Ebola has been hacked to death by a machete-wielding mob of youths, officials have said. Another health worker was…
Uganda: Parents Urged to Vaccinate Children Against Polio
[Nile Post] Parents across Uganda have been urged to ensure their children receive all recommended polio vaccines as health stakeholders renew efforts to prevent the disease from returning…
Large meta-analysis sheds new light on how SGLT2 inhibitors affect blood and iron parameters
Research led by internist-nephrologist Dr. Michele Eisenga shows that SGLT2 inhibitors, a class of drugs widely used to treat type 2 diabetes, heart failure and chronic kidney disease,…
South African Labs Strive for Africa’s Biopharma Sovereignty
Africa still imports 99% of its routine vaccines and 70–90% of its biopharmaceuticals. The Africa CDC warns this vulnerability could cost the continent up to $1.1 trillion in…
Ebola patient evacuated from Nigeria to Switzerland
A woman infected with the Ebola virus and her husband, a Swiss diplomat, were flown from Nigeria to hospitals in Switzerland on Monday, Swiss authorities said. The Ugandan-born…